Valuation : Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.41M 1.33M 1.21M 2.27M 156M 2.29M 15.72M 6.11M 79.15M 6.16M 6.03M 262M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7M 6.57M 6M 11.27M 773M 11.35M 77.87M 30.3M 392M 30.52M 29.86M 1.3B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
3 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
-1.53%-6.97%+57.78%+109.31% 1,047B
-0.59%-2.36%+49.72%+64.89% 646B
+0.28%-2.99%+21.08%+74.61% 451B
-1.64%-4.75%+35.59%+35.54% 355B
-0.39%-2.76%+21.39%+38.01% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-0.40%-2.78%+50.39%+68.33% 234B
-1.05%-2.29%-19.91%-54.10% 203B
+0.48%-0.17%+29.97%+91.54% 181B
Average +989.28%-2.41%+24.75%+43.96% 365.93B
Weighted average by Cap. -0.96%-3.46%+36.76%+65.08%

Financials

2007 2008
Net sales 23.47M 20.2M 18.97M 17.32M 32.53M 2.23B 32.77M 225M 87.47M 1.13B 88.11M 86.19M 3.75B 25.96M 22.35M 20.99M 19.16M 35.99M 2.47B 36.25M 249M 96.76M 1.25B 97.47M 95.35M 4.15B
Net income -20.86M -17.96M -16.86M -15.39M -28.92M -1.98B -29.12M -200M -77.74M -1.01B -78.32M -76.61M -3.33B -4.01M -3.45M -3.24M -2.96M -5.55M -381M -5.59M -38.38M -14.93M -193M -15.04M -14.71M -640M
Net Debt 18.79M 16.18M 15.19M 13.87M 26.05M 1.79B 26.24M 180M 70.04M 907M 70.55M 69.02M 3B 6.49M 5.59M 5.25M 4.79M 9M 617M 9.06M 62.16M 24.18M 313M 24.36M 23.83M 1.04B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock